Menu

MiNK Therapeutics, Inc. INKT

Full chart Compare
Set alert

Price alert · INKT

All alert types
10.35 USD +0.41 (+4.12%)

At closeNov 9, 2026, 5:46 AM EST

11.00 +0.65 +6.28%

Pre-market · Nov 9, 5:46 AM ET

9.82 Day range 10.88
8.48 52-week range 16.93
YTD
-7.17%
1 year
-24.23%

Revenue & Expenses

Other Operating Income → Expenses: $551.24KExpenses → Selling, General & Admin: $3.83MExpenses → Research & Development: $19.65MExpenses → Interest Expense: $1.56MGross Profit → Expenses: $689.63KRevenue → Gross Profit: $689.63KNet Loss → Expenses: $23.80MOther Operating Income$551.24KGross Profit$689.63KNet Loss$23.80MExpenses$25.04MSelling, General & Admin$3.83MResearch & Development$19.65MInterest Expense$1.56MRevenue$689.63K

Latest period ending Dec 31, 2025 · select a line to chart its full history

INKT annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-12.64M-11.29M-22.92M-30.95M-28.36M
-12.49M-10.78M-22.46M-27.99M-30.21M
-2.93-2.86-6.54-8.30-11.60
INKT annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
13.36M4.58M3.37M19.64M38.89M
14.24M5.72M4.55M21.47M40.24M
28.47M25.31M22.61M21.87M16.47M
5.18M4.92M000
-14.23M-19.59M-18.06M-401.30K23.78M
INKT annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-5.93M-9.56M-15.76M-18.87M-12.83M
14.72M10.82M-407.17K-155.60K49.26M
8.78M1.21M-16.27M-19.25M36.20M